Fasting Insulin Blood Test: The Early Warning for Insulin Resistance

Why Glucose Alone Misses the Problem

Standard panels measure fasting glucose — not insulin. The fundamental problem is that blood sugar stays normal for years while insulin resistance develops. The pancreas compensates by flooding the bloodstream with increasing amounts of insulin to force glucose into cells. By the time fasting glucose climbs into the pre-diabetic range, insulin resistance has often been present for 10–15 years. Fasting insulin catches this compensation early.

What Optimal Fasting Insulin Looks Like

Category	Fasting Insulin (µIU/mL)	Clinical Significance
Optimal	Below 5	Excellent insulin sensitivity
Good	5–10	Normal insulin sensitivity
Borderline elevated	10–15	Early insulin resistance developing
Elevated	15–25	Significant insulin resistance
High	Above 25	Marked resistance (lab "normal" often extends here)

Note that most US lab reference ranges extend to 25 µIU/mL — meaning substantial insulin resistance can appear "normal" on a standard report. The research-backed optimal target, based on metabolically healthy populations, is below 5–8 µIU/mL.

HOMA-IR: Turning Two Numbers Into a Risk Score

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) combines fasting insulin and fasting glucose into a single insulin resistance index. The formula: HOMA-IR = (fasting insulin µIU/mL × fasting glucose mmol/L) ÷ 22.5. Glucose in mg/dL should first be converted: mg/dL ÷ 18 = mmol/L.

A HOMA-IR below 1.0 indicates excellent insulin sensitivity. Values of 1.0–2.0 are normal. Above 2.0 suggests developing insulin resistance; above 2.9 indicates significant insulin resistance in most published studies.

What Insulin Resistance Causes

Chronically elevated insulin drives visceral fat accumulation, which itself worsens insulin resistance in a self-amplifying cycle. It raises triglycerides, lowers HDL, elevates blood pressure, promotes systemic inflammation, accelerates arterial plaque formation, and predicts risk of type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, PCOS, dementia, and several cancers. Insulin resistance is arguably the most important modifiable metabolic risk factor most people have never tested.

How to Improve Fasting Insulin

Resistance training is the single most potent intervention — it increases GLUT4 transporter density in muscle, enabling insulin-independent glucose uptake. Aerobic exercise and walking after meals both reduce post-meal glucose and insulin spikes. Reducing refined carbohydrates and ultra-processed foods lowers the carbohydrate load the pancreas must manage. Improving sleep quality, reducing visceral fat, and managing chronic stress all improve fasting insulin over weeks to months. Fasting insulin is the best single biomarker for monitoring whether metabolic interventions are working.